EPI-Q

EPI-Q is a premier health economics and outcomes research (HEOR) and market access consultancy dedicated to demonstrating the real-world value of medical interventions. By leveraging advanced data analytics, comparative effectiveness studies, and strategic value dossiers, EPI-Q helps life science innovators navigate complex global reimbursement landscapes and optimize market entry.
Purchase from EPI-Q on Scientist.com

Epidemiologists, economists, statisticians, physicians, pharmacists, nurses and quality improvement specialists sit on the resident staff of this Chicago firm, which opened its doors in 1994. Real-world evidence work runs to pragmatic and traditional clinical trials, claims and electronic medical record analysis, disease registries, chart reviews, and surveys of patients, clinicians and payors. Economic studies cover cost effectiveness and budget impact analysis together with preference and utility elicitation, while a separate practice handles direct and indirect meta-analysis and epidemiologic modeling. Population health projects assess burden of disease and build system-integrated data analysis tools; market access engagements produce evidence dossiers and formulary evaluations; and quality improvement work reaches treatment decision aids and time-in-motion studies. Outputs range from peer-reviewed manuscripts to population-based tools, interactive economic and decision models, and shared decision-making aids.